174 related articles for article (PubMed ID: 2952730)
41. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.
Phillips JH; Lanier LL
J Immunol; 1986 Mar; 136(5):1579-85. PubMed ID: 2419407
[TBL] [Abstract][Full Text] [Related]
42. Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies.
Lubeck MD; Kimoto Y; Steplewski Z; Koprowski H
Cell Immunol; 1988 Jan; 111(1):107-17. PubMed ID: 3338092
[TBL] [Abstract][Full Text] [Related]
43. T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors.
Smith KG; Austyn JM; Hariri G; Beverley PC; Morris PJ
Eur J Immunol; 1986 May; 16(5):478-86. PubMed ID: 2938973
[TBL] [Abstract][Full Text] [Related]
44. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
45. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
[TBL] [Abstract][Full Text] [Related]
46. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
47. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
Schubert J; Heiken H; Jacobs R; Delany P; Witte T; Schmidt RE
Nat Immun Cell Growth Regul; 1990; 9(2):103-11. PubMed ID: 2141105
[TBL] [Abstract][Full Text] [Related]
48. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
[TBL] [Abstract][Full Text] [Related]
49. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
Mujoo K; Kipps TJ; Yang HM; Cheresh DA; Wargalla U; Sander DJ; Reisfeld RA
Cancer Res; 1989 Jun; 49(11):2857-61. PubMed ID: 2720646
[TBL] [Abstract][Full Text] [Related]
50. High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.
Preithner S; Elm S; Lippold S; Locher M; Wolf A; da Silva AJ; Baeuerle PA; Prang NS
Mol Immunol; 2006 Mar; 43(8):1183-93. PubMed ID: 16102830
[TBL] [Abstract][Full Text] [Related]
51. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
52. Characterization of human K cells by surface antigens and morphology at the single cell level.
Wåhlin B; Perlmann P
J Immunol; 1983 Nov; 131(5):2340-7. PubMed ID: 6226741
[TBL] [Abstract][Full Text] [Related]
53. Cell-mediated lysis of tumor targets directed by murine monoclonal antibodies of IgM and all IgG isotypes.
Ralph P; Nakoinz I
J Immunol; 1983 Aug; 131(2):1028-31. PubMed ID: 6134771
[TBL] [Abstract][Full Text] [Related]
54. Immune interferon modulation of in vitro murine anti-human T cell monoclonal antibody-mediated cytotoxicity.
Dillman RO; Johnson DE; Shawler DL
J Immunol; 1986 Jan; 136(2):728-31. PubMed ID: 3079792
[TBL] [Abstract][Full Text] [Related]
55. Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.
Garcia de Palazzo I; Holmes M; Gercel-Taylor C; Weiner LM
Cancer Res; 1992 Oct; 52(20):5713-9. PubMed ID: 1394194
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
Drebin JA; Link VC; Greene MI
Oncogene; 1988 Apr; 2(4):387-94. PubMed ID: 2896329
[TBL] [Abstract][Full Text] [Related]
57. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
Rashid A; Auchincloss H; Sharon J
J Immunol; 1992 Mar; 148(5):1382-8. PubMed ID: 1538121
[TBL] [Abstract][Full Text] [Related]
58. A flow cytometric rosetting assay for the analysis of IgG-Fc receptor interactions.
Tuijnman WB; Van de Winkel JG; Capel PJ
J Immunol Methods; 1990 Mar; 127(2):207-14. PubMed ID: 2138200
[TBL] [Abstract][Full Text] [Related]
59. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
[TBL] [Abstract][Full Text] [Related]
60. Expression of Fc gamma receptors on splenic T cells of mice infected with Plasmodium chabaudi adami.
Langhorne J; Titus JA
Eur J Immunol; 1988 Jan; 18(1):1-6. PubMed ID: 2964371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]